SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Accepts Orexo’s Resubmitted IZIPRY Application for Review

Orexo said the FDA accepted its resubmitted registration application for IZIPRY for review.

Related stories